Schaller Sandra, Mauskopf Josephine, Kriza Christine, Wahlster Philip, Kolominsky-Rabas Peter L
Interdisciplinary Centre for Health Technology Assessment (HTA) and Public Health, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Int J Geriatr Psychiatry. 2015 Feb;30(2):111-29. doi: 10.1002/gps.4198. Epub 2014 Oct 16.
Because of the increasing prevalence of dementia worldwide, combined with limited healthcare expenditures, a better understanding of the main cost drivers of dementia in different care settings is needed.
A systematic review of cost-of-illness (COI) studies in dementia was conducted from 2003 to 2012, searching the following databases: PubMed (Medline), Cochrane Library, ScienceDirect (Embase) and National Health Service Economic Evaluations Database. Costs (per patient) by care setting were analyzed for total, direct, indirect and informal costs and related to the following: (1) cost perspective and (2) disease severity.
In total, 27 studies from 14 different healthcare systems were evaluated. In the included studies, total annual costs for dementia of up to $70,911 per patient (mixed setting) were estimated (average estimate of total costs = $30,554). The shares of cost categories in the total costs for dementia indicate significant differences for different care settings. Overall main cost drivers of dementia are informal costs due to home based long term care and nursing home expenditures rather than direct medical costs (inpatient and outpatient services, medication).
The results of this review highlight the significant economic burden of dementia for patients, families and healthcare systems and thus are important for future health policy planning. The significant variation of cost estimates for different care settings underlines the need to understand and address the financial burden of dementia from both perspectives. For health policy planning in dementia, future COI studies should follow a quality standard protocol with clearly defined cost components and separate estimates by care setting and disease severity.
鉴于全球痴呆症患病率不断上升,同时医疗保健支出有限,需要更好地了解不同护理环境中痴呆症的主要成本驱动因素。
对2003年至2012年痴呆症疾病成本(COI)研究进行系统综述,检索以下数据库:PubMed(Medline)、Cochrane图书馆、ScienceDirect(Embase)和国家卫生服务经济评估数据库。分析了不同护理环境下每位患者的总成本、直接成本、间接成本和非正式成本,并与以下因素相关:(1)成本视角;(2)疾病严重程度。
总共评估了来自14个不同医疗系统的27项研究。在所纳入的研究中,估计痴呆症患者的年度总成本高达每人70,911美元(混合环境)(总成本平均估计值 = 30,554美元)。痴呆症总成本中各类成本的占比在不同护理环境下存在显著差异。痴呆症的总体主要成本驱动因素是家庭长期护理和养老院支出产生的非正式成本,而非直接医疗成本(住院和门诊服务、药物治疗)。
本综述结果凸显了痴呆症给患者、家庭和医疗系统带来的巨大经济负担,因此对未来卫生政策规划具有重要意义。不同护理环境下成本估计的显著差异强调了从两个角度理解和应对痴呆症经济负担的必要性。对于痴呆症的卫生政策规划,未来的疾病成本研究应遵循质量标准方案,明确界定成本组成部分,并按护理环境和疾病严重程度分别进行估计。